Clinical Trial Update: Induced Adult Refractory Active Crohn's Disease Clinical Relieving by Using Thalidomide [EARLY_Phase 1]

View source ↗

Summary

Early-stage Phase 1 clinical trial update evaluating thalidomide for adults with refractory active Crohn's disease; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn Disease | EARLY_Phase 1 | Status: UNKNOWN